Studies on the role of individual sphingolipid metabolic enzymes in oncogenic transformation and cancer phenotype have focused primarily on SPHK1 and GCS, with a number of studies focusing on acid ceramidase and other enzymes. This evidence concerns the gene UGCG and cancer.